We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Don’t invest unless you’re prepared to lose all the money you invest. NextFin promotes high - risk investments and you are unlikely to be protected if something goes wrong.
Take 2 minutes to learn more.

Equity Crowdfunding Pitches

Showing results
Gendius is a company that aims to bring pharmaceuticals and health economics, through clinical research and evidence, to the mobile health market. Their latest innovation, Intellin, is an intelligent remote management diabetes platform, with over 140,000 downloads so far. The COVID-19 crisis has highlighted the need for remote home monitoring of patients, and the company feels that its product is a suitable contender in this domain. Intellin has a reliable connection to over 150 medical devices and apps, and also consists of a two-way communication setup with a healthcare professional via a secure dashboard. Gendius is registered as an approved vendor with AstraZeneca in Saudi Arabia and looks to establish deeper relations with the National Health Service (UK) to create a demand for its product. The company will use the investment to scale its business globally, drive commercialisation, offer an opportunity to its stakeholders, and target venture capital.

Pitch Rated

84%

Gold

rating powered by

CROWD RATING™

days to go: Expired investment: £386,829
Pedal Me uses high-tech cargo bikes, trailers and trained riders to provide delivery & taxi services when needed. The company offers a solution that will out-perform motors in car-centric cities as bike-friendly measures like bike lanes are introduced. As of now, the company has 32 bikes and 45 staff in total. It has witnessed a strong MoM growth (19% on avg). The trips provided by Pedal Me has negligible carbon footprint in comparison with vans, taxis or electric vehicles. With the funds, the company will improve the technology, maintain speed with demand, develop the staff and balance the process.

Pitch Rated

70%

Overall

rating powered by

CROWD RATING™

days to go: Expired investment: £421,330
OvuSense is a women's health monitoring platform offering continuous insights into the reproductive cycle. With over 45,000 users and 10 patents, they aim to expand through partnerships, starting with a large IVF clinic chain. Addressing underdiagnosed health issues, their platform provides accurate cycle monitoring, health screening, and treatment tracking. Backed by institutional investors, OvuSense stands out for its predictive capabilities and accuracy in ovulation tracking, empowering women's fertility control.
days to go: Expired investment: £169,920
Cambridge Nutraceuticals develop and sell healthcare supplements that are proven to provide health benefits. Their products ar ecurrently on shelves in a number of the large high street retailers such as Holland & Barrett and Boots.
days to go: Expired investment: £1,077,710
Track is a property and money managing app designed for homeowners. It is backed pre-seed by Pi Labs which is Europe's leading proptech VC. The company is run by an experienced management team with a previous exit. Through products like TrackPro, Track Digital Deed, and Track Home Improvement Loan, the company provides a drastically improved experience of homeowner finances, from AI-powered home valuations and seamless expenses tracking, to intelligent goal planning. With the proceeds, Track will accelerate growth and traction in 2020.
days to go: Expired investment: £167,619
PathCloud aims to assemble the global clinical diagnostics resources and data and make them safely available and helpful. The company has created and tested one of the first scalable clinical diagnostics management platforms. It currently has 20,000 clinicians partner networks and 92 registered clinicians. Additionally, it has a network across 48 counties, has over 100 providers, over 3500 diagnostics tests registered and over 10,000 patients by partner telemedicine networks. These funds will be used to gain a significant portion of diagnostics supplier agreements towards the scaling objective, increase efforts towards the international markets and NHS and pursue telemedicine networks.
days to go: Expired investment: £81,720
Riversimple is a vehicle manufacturer and assistance provider exploring ‘next-generation’ electric vehicles. It offers its customers the first inexpensive, fun-to-drive and easy eco-car, delivered with a complete and cost-transparent subscription service. Riversimple has gained an investor base of over 950 shareholders from 21 countries including NZ, Japan, India and many more. The company has already raised over £2M, and its next step is to grow the engineering team and boost the volume of production engineering to enable it to reach commercialisation by 2021.
days to go: Expired investment: £839,958
Veluba is a zero-emission transport solution for London. It is an application-hailed and pedal-powered eco-cab service for Central London which aims to provide a faster and cheaper solution for its over-polluted and over-congested capital city. The company has 30 Veluba cabs ready to go with and have just launched their app. The vehicles are designed and driven with safety at the forefront and drivers are fully insured. Each Veluba® is provided with digital signage screens, giving prominent ad space, and the possibility for an additional revenue stream. Veluba aims to expand beyond the first depot to reach more of London and become a key part of the city’s growing eco-transport infrastructure. The investment will enable the company to employ additional drivers.

Pitch Rated

76%

Gold

rating powered by

CROWD RATING™

days to go: Expired investment: £78,590
Vaboo is a customisable perks and engagement platform for the private rented sector. The platform allows clients to enhance their brand image and add value to their service through engaging communication, giveaways, and prize draws, designed to attract customers to the platform on a regular basis. Addressing core problems of the sector, Vaboo not only helps clients built their brand value, it also offers them a competitive edge in the market. By April 2019, 350+ agency branches will have brought 50,000+ renters on to the platform. Moreover, Vaboo is estimated to achieve at least a 10% market share (approx. 2000 branches) which will generate annual recurring revenues of over £4m. With the fund raised, Vaboo will focus on team expansion, product development, and sales.
days to go: Expired investment: £172,077
OnCare is a digital care management software that is digitising elderly care, creating a global care marketplace via the OpenTable model to care. OnCare provides care agencies with the power to plan, manage and enhance care delivery and staff communication. Their mission is to make care easier for everyone. OnCare is currently live with over 110 home-care agencies around the UK, and more than 1100 care workers. The company is planning to enter markets of Hong Kong, Canada and Israel. With the proceeds, the company will use this fund for people, office space, technology, software, hosting and marketing.

Pitch Rated

72%

Overall

rating powered by

CROWD RATING™

days to go: Expired investment: £96,040
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph